Diclofenac sodium

Diclofenac sodium

Cat Number
API0231517
CAS Number
15307-79-6

If you have any other questions, please contact our experts.

CAS Number
15307-79-6
EINECS
239-346-4
Storage
Store at room temperature
Synonyms
Diclofenac sodium salt; Sodium diclofenac; Solaraze; Neriodin; Prophenatin; Voltaren; Diclophenac sodium
Molecular Formula
C14H10Cl2NNaO2
Molecular Weight
318.13
Smiles
C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]
Appearance
White to off-white powder
Melting Point
288-290℃
Boiling Point
412℃
General Description
Diclofenac sodium is a potent nonsteroidal anti-inflammatory drug (NSAID) of the phenylacetic acid class, available in a wide variety of formulations including oral, topical, ophthalmic, and parenteral preparations. It is one of the most commonly prescribed NSAIDs globally, characterized by its balanced inhibition of cyclooxygenase enzymes and favorable analgesic properties. The molecule exhibits high protein binding and extensive tissue penetration.
Mechanism of Action
It exerts its effects through non-selective, reversible inhibition of both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), thereby reducing the synthesis of prostaglandins and thromboxane. The drug demonstrates preferential distribution to inflamed tissues, where it achieves higher concentrations than in plasma. This results in potent anti-inflammatory, analgesic, and antipyretic effects with a predictable dose-response relationship.
Application
Its applications span the management of acute and chronic pain, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal injuries. The topical formulation is widely used for localized pain relief, such as in actinic keratosis treatment, while the ophthalmic solution is indicated for postoperative inflammation following cataract surgery. Due to cardiovascular and gastrointestinal risk profiles, it is used at the lowest effective dose for the shortest duration.

A randomized controlled trial compared diclofenac sodium plus occlusal splint versus vitamin D supplementation plus occlusal splint in 40 patients with myofascial pain and vitamin D deficiency. Both groups showed significant and comparable improvements in mouth opening and visual analog scale pain scores at 1, 4, and 12 weeks. The changes in primary outcomes were homogeneous between groups, indicating equivalent efficacy. The authors conclude that vitamin D supplementation offers anti‑inflammatory and analgesic effects comparable to NSAIDs for managing myofascial pain associated with vitamin D deficiency, suggesting it as an alternative treatment option.

Fig. 1 CONSORT Flow Diagram. (Kahraman NH, Tunç SK, 2025) Fig. 1 CONSORT Flow Diagram. (Kahraman NH, Tunç SK, 2025)

References

  1. Kahraman NH, Tunç SK. Comparative evaluation of the effects of diclofenac sodium and vitamin D supplementation on symptoms in individuals with myofascial pain and vitamin D deficiency: a randomized controlled clinical trial. BMC Oral Health. 2025; 25(1):1383.

Hydrogels of sodium alginate co‑polymerized with 2‑acrylamido‑2‑methyl propane sulphonic acid (AMPS) were fabricated via free radical polymerization for sustained diclofenac sodium delivery. The hydrogels showed pH‑independent swelling due to AMPS, with higher drug release at pH 7.4 than at pH 1.2. Sol‑gel analysis indicated increased gel fraction with higher concentrations of sodium alginate, AMPS, and cross‑linker. These naturally derived polymer hydrogels represent a potential sustained release platform for diclofenac sodium, offering controlled drug delivery over extended periods.

Fig. 2 FTIR spectra of (A) DS, (B) SA, (C) AMPS, (D) unloaded SA-co-poly(AMPS) hydrogeI (E) loaded SA-co-poly(AMPS) hydrogel. (Suhail M, <i>et al</i>., 2021) Fig. 2 FTIR spectra of (A) DS, (B) SA, (C) AMPS, (D) unloaded SA-co-poly(AMPS) hydrogeI (E) loaded SA-co-poly(AMPS) hydrogel. (Suhail M, et al., 2021)

References

  1. Suhail M, et al. Fabrication and Characterization of Diclofenac Sodium Loaded Hydrogels of Sodium Alginate as Sustained Release Carrier. Gels. 2021; 7(1):10.

Does Diclofenac Sodium require protection from light during storage?

Yes, it is photosensitive. Exposure to light can cause discoloration and degradation. Store in light-resistant, well-closed containers.

What is the recommended storage temperature for Diclofenac Sodium?

Store at controlled room temperature, between 15°C and 30°C. Avoid excessive heat and humidity, which can cause caking and accelerate degradation.

Is Diclofenac Sodium hygroscopic, and how is this managed during storage?

It exhibits moderate hygroscopicity. We package it in moisture-barrier bags with desiccant to prevent moisture absorption and maintain free-flowing properties.

How is the impurity profile of Diclofenac Sodium monitored for topical and parenteral formulations?

We use a stability-indicating HPLC method to monitor related substances, including the known impurity 1-(2,6-dichlorophenyl)indolin-2-one, ensuring compliance with pharmacopoeial limits.
You Might Also Like
Pranoprofen
Pranoprofen

Cat NO.: API52549174
CAS NO.: 52549-17-4

View Details
Ketorolac Tromethamine
Ketorolac Tromethamine

Cat NO.: API74103074
CAS NO.: 74103-07-4

View Details
Piroxicam
Piroxicam

Cat NO.: API36322904
CAS NO.: 36322-90-4

View Details
Phenylbutazone
Phenylbutazone

Cat NO.: API50339
CAS NO.: 50-33-9

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top